Inventor · disambiguated record
Gilles Bignan
Also filed as: BIGNAN GILLES · BIGNAN GILLES C
24 granted patents·14 pending applications·82 citations·filing 2003–2023
94Inventor score
Files withJANSSEN PHARMACEUTICA NV16JANSSEN BIOTECH INC8BIGNAN GILLES5BATTISTA KATHLEEN2BIGNAN GILLES C2
Top patents by PatentIndex Score
38 records- 0192US8685990B2Pyrimidine compounds as delta opioid receptor modulatorsJANSSEN PHARMACEUTICA NV·Filed 2013·Granted Apr 1, 2014·19 cites·3 claims
- 0286US10077261B2Imidazolin-5-one derivative useful as FASN inhibitors for the treatment of cancerJANSSEN PHARMACEUTICA NV·Filed 2015·Granted Sep 18, 2018·7 cites·16 claims
- 0384US7582649B2Hydroxy alkyl substituted 1,3,8-triazaspiro[4.5]decan-4-one derivatives useful for the treatment of ORL-1 receptor mediated disordersJANSSEN PHARMACEUTICA NV·Filed 2005·Granted Sep 1, 2009·7 cites·14 claims
- 0483US7579356B2Thia-tetraazaacenaphthylene kinase inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2006·Granted Aug 25, 2009·9 cites·27 claims
- 0582US7655670B23-spirocyclic indolyl derivatives useful as ORL-1 receptor modulatorsJANSSEN PHARMACEUTICA NV·Filed 2006·Granted Feb 2, 2010·8 cites·4 claims
- 0679US7081463B2Hydroxy alkyl substituted 1,3,8-Triazaspiro[4.5]decan-4-one derivatives useful for the treatment of orl-1receptor mediated disordersJANSSEN PHARMACEUTICA NV·Filed 2003·Granted Jul 25, 2006·11 cites·15 claims
- 0776US8445690B2Aminothiazolones as estrogen related receptor-alpha modulatorsBIGNAN GILLES·Filed 2011·Granted May 21, 2013·4 cites·23 claims
- 0875US8263781B2Substituted aminothiazolone indazoles as estrogen related receptor-alpha modulatorsBIGNAN GILLES·Filed 2010·Granted Sep 11, 2012·3 cites·22 claims
- 0975US8153791B2Substituted pyrimidinyl oxime kinase inhibitorsXU GUOZHANG·Filed 2006·Granted Apr 10, 2012·5 cites·24 claims
- 1074US11597746B2Cyclic dinucleotides as sting agonistsJANSSEN BIOTECH INC·Filed 2019·Granted Mar 7, 2023·1 cites·53 claims
- 1173US10501469B2Substituted thiohydantoin derivatives as androgen receptor antagonistsJANSSEN PHARMACEUTICA NV·Filed 2018·Granted Dec 10, 2019·1 cites·53 claims
- 1273US8796256B2Substituted thiazolidinedione indazoles, indoles and benzotriazoles as estrogen-related receptor-α modulatorsBIGNAN GILLES·Filed 2011·Granted Aug 5, 2014·3 cites·28 claims
- 1373US2023287034A1Cyclic dinucleotides as sting agonistsJANSSEN BIOTECH INC·Filed 2023·Application pending·0 cites
- 1471US2023144627A1Cyclic Dinucleotides As Sting AgonistsJANSSEN BIOTECH INC·Filed 2022·Application pending·0 cites
- 1568US8580832B2Substituted phenoxy aminothiazolones as estrogen related receptor-α modulatorsGAUL MICHAEL·Filed 2008·Granted Nov 12, 2013·1 cites·6 claims
- 1667US10981926B2Substituted thiohydantoin derivatives as androgen receptor antagonistsJANSSEN PHARMACEUTICA NV·Filed 2019·Granted Apr 20, 2021·0 cites·51 claims
- 1767US8778956B2Hydroxy alkyl substituted 1,3,8-triazaspiro[4.5]decan-4-one derivatives useful for the treatment of ORL-1 receptor mediated disordersBATTISTA KATHLEEN·Filed 2008·Granted Jul 15, 2014·1 cites·15 claims
- 1867US8399681B2Substituted aminothiazolone indazoles as estrogen related receptor-alpha modulatorsBIGNAN GILLES·Filed 2012·Granted Mar 19, 2013·1 cites·14 claims
- 1967US2023146410A1Cyclic dinucleotides as sting agonistsJANSSEN BIOTECH INC·Filed 2022·Application pending·0 cites
- 2066US8426604B2Aminothiazolones as estrogen related receptor-alpha modulatorsBIGNAN GILLES·Filed 2011·Granted Apr 23, 2013·1 cites·23 claims
- 2162US2019241542A1Substituted hydantoin and thiohydantoin derivatives as androgen receptor antagonistsJANSSEN PHARMACEUTICA NV·Filed 2019·Application pending·0 cites
- 2260US2019337924A1Substituted hydantoin and thiohydantoin derivatives as androgen receptor antagonistsJANSSEN PHARMACEUTICA NV·Filed 2019·Application pending·0 cites
- 2359US11492367B2Cyclic dinucleotides as sting agonistsJANSSEN BIOTECH INC·Filed 2018·Granted Nov 8, 2022·0 cites·19 claims
- 2459US2019330190A1Substituted hydantoin and thiohydantoin derivatives as androgen receptor antagonistsJANSSEN PHARMACEUTICA NV·Filed 2019·Application pending·0 cites
- 2557US2018009785A1Substituted hydantoin and thiohydantoin derivatives as androgen receptor antagonistsJANSSEN PHARMACEUTICA NV·Filed 2017·Application pending·0 cites
- 2654US11472830B2Cyclic dinucleotides as sting agonistsJANSSEN BIOTECH INC·Filed 2017·Granted Oct 18, 2022·0 cites·19 claims
- 2754US2018327401A1Imidazolin-5-one derivative useful as fasn inhibitors for the treatment of cancerJANSSEN PHARMACEUTICA NV·Filed 2018·Application pending·0 cites
- 2850US2021009630A1Cyclic dinucleotides as sting agonistsJANSSEN BIOTECH INC·Filed 2018·Application pending·0 cites
- 2949US10000502B2Substituted thiohydantoin derivatives as androgen receptor antagonistsJANSSEN PHARMACEUTICA NV·Filed 2017·Granted Jun 19, 2018·0 cites·25 claims
- 3045US8513271B2Pyrimidine compounds as delta opioid receptor modulatorsCOATS STEVEN J·Filed 2010·Granted Aug 20, 2013·0 cites·25 claims
- 3145US8367825B2Substituted pyrimidinyl oxime kinase inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2012·Granted Feb 5, 2013·0 cites·13 claims
- 3245US2010076003A15-oxazolidin-2-one substituted 1,3,8-triazaspiro[4.5]decan-4-one derivatives useful as orl-1 receptor modulatorsBATTISTA KATHLEEN·Filed 2009·Application pending·0 cites
- 3343US11021511B2Cyclic dinucleotides as sting agonistsJANSSEN BIOTECH INC·Filed 2018·Granted Jun 1, 2021·0 cites·14 claims
- 3443US2008108611A1Substituted thienopyrimidine kinase inhibitorsBATTISTA KATHLEEN A·Filed 2007·Application pending·0 cites
- 3541US2019209539A1Thiohydantoin androgen receptor antagonists for the treatment of cancerJANSSEN PHARMACEUTICA NV·Filed 2017·Application pending·0 cites
- 3640US2018008587A1Thiohydantoin androgen receptor antagonists for the treatment of cancerJaressen Pharmaceutica NV·Filed 2017·Application pending·0 cites
- 3736US8741916B21,3,8-trisubstituted-1,3,8-triaza-spiro[4.5]decan-4-one derivatives as ligands of the ORL-1 receptorBIGNAN GILLES C·Filed 2008·Granted Jun 3, 2014·0 cites·34 claims
- 3836US2008015214A13-piperidin-4-yl-indole orl-1 receptor modulatorsBIGNAN GILLES C·Filed 2006·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Gilles Bignan files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →